版本:
中国

BRIEF-FDA grants fast track designation to Axovant's nelotanserin

June 19 Axovant Sciences Ltd

* FDA grants fast track designation to Axovant's nelotanserin for visual hallucinations in dementia with lewy bodies

* Axovant Sciences - FDA granted fast track designation to investigational drug nelotanserin for treatment of visual hallucinations disorder in dementia with lewy bodies Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐